Skip to main content

Day: December 15, 2020

Air Canada Announces Offering of Shares

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESMONTREAL, Dec. 15, 2020 (GLOBE NEWSWIRE) — Air Canada (TSX:AC) (the “Company”) today announced that it has commenced an overnight marketed public offering of Class A Variable Voting Shares and/or Class B Voting Shares of the Company (“Shares”) for gross proceeds of approximately C$850 million (the “Offering”).The Company intends to grant the underwriters an option to purchase up to an additional 15% of the Shares in the Offering, exercisable in whole or in part at any time until 30 days after closing of the Offering.The Offering will be priced in the context of the market with the price and other final terms to be determined at the time of entering into an underwriting agreement for the Offering.Completion of the Offering will be subject to various...

Continue reading

SJI Announces Green Hydrogen Partnership with Atlantic Shores Offshore Wind

FOLSOM, NJ, Dec. 15, 2020 (GLOBE NEWSWIRE) —                                                                                                 Media Contact: Dominick DiRocco(609) 561-9000 ext. 4262ddirocco@sjindustries.com                                                                                                          Investor Contact: Dan Fidell(609) 561-9000 ext. 7027dfidell@sjindustries.comFOR IMMEDIATE RELEASESJI Announces Green Hydrogen Partnership with Atlantic Shores Offshore WindFOLSOM, NJ, December 15, 2020 – SJI (NYSE: SJI) remains committed to advancing the clean energy and sustainability goals of New Jersey and our region. Consistent with this commitment, we are excited to announce today a partnership with Atlantic Shores Offshore Wind (Atlantic Shores) to collaborate on a green hydrogen pilot program, which will...

Continue reading

Virginia National Bankshares Corporation Announces Cash Dividend

CHARLOTTESVILLE, Va., Dec. 15, 2020 (GLOBE NEWSWIRE) — Virginia National Bankshares Corporation (the “Company”) (OTCQX: VABK) announced today that on December 10, 2020, its Board of Directors declared a quarterly cash dividend of $0.30 per share to be paid on January 5, 2021 to shareholders of record as of December 22, 2020. The quarterly cash dividend represents an annual yield to shareholders of approximately 4.40% based on the closing price of the Company’s common stock on December 14, 2020.About Virginia National Bankshares CorporationVirginia National Bankshares Corporation, headquartered in Charlottesville, Virginia, is the bank holding company for Virginia National Bank (the “Bank”). The Bank has four banking offices in Charlottesville and one in Winchester, and offers loan, deposit and treasury management services in Richmond,...

Continue reading

Leslie’s, Inc. to Report Fourth Quarter and Full Fiscal 2020 Financial Results on December 21, 2020

PHOENIX, Dec. 15, 2020 (GLOBE NEWSWIRE) — Leslie’s, Inc. (“Leslie’s” or “Company”; NASDAQ:LESL), the largest and most trusted direct-to-consumer brand in the U.S. pool and spa care industry, today announced that its financial results for the fourth quarter and full fiscal 2020 will be released before market open on Monday, December 21, 2020. The Company will host a conference call at 9:00 a.m. Eastern Time to discuss the financial results.Investors and analysts interested in participating in the call are invited to dial 877-407-0784 (international callers please dial 1-201-689-8560) approximately 10 minutes prior to the start of the call. A live audio webcast of the conference call will be available online at https://ir.lesliespool.com/.A recorded replay of the conference call will be available within approximately...

Continue reading

ImmuCell Announces Restructuring of its Bank Debt

PORTLAND, Maine, Dec. 15, 2020 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced a restructuring of its bank debt.Today, the Company secured a $1.5 million loan from its existing lender, Gorham Savings Bank, with a seven-year term and amortization at 3.5% per annum. Approximately $624,000 of the proceeds were used to pay down the outstanding balance on its mortgage loan with Gorham Savings Bank. In connection with that pay-down, the bank released the $1.4 million in funds that had been held by the bank in a restricted collateral account since the Company’s March 2020 financing. The remaining proceeds...

Continue reading

Apex Global Brands Reports Third Quarter 2021 Financial Results

Third Quarter Fiscal 2021 Highlights versus Third Quarter Fiscal 2020:Revenues declined to $4.1 million from $4.9 millionAdjusted EBITDA increased to $1.8 million from $1.7 millionNet loss improved to $6.0 million compared to a loss of $6.8 millionSG&A expenses declined to $2.3 million from $3.2 millionSHERMAN OAKS, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) — Apex Global Brands (OTCBB: APEX), a global brand management and licensing organization that markets a portfolio of high-equity lifestyle brands it owns, creates and elevates, today reported financial results for its third quarter of Fiscal 2021, which ended October 31, 2020.“Consistent with the overall retail sector, we continued to see challenges in the third quarter,” said Henry Stupp, Chief Executive Officer of Apex Global Brands.  “The COVID-19 pandemic continues to impact...

Continue reading

4D Molecular Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

EMERYVILLE, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics, Inc. (4DMT), a clinical-stage gene therapy company harnessing the power of directed evolution for targeted gene therapies, announced today the closing of its initial public offering of 9,660,000 shares of its common stock, including 1,260,000 shares sold pursuant to the full exercise of the underwriters’ option to purchase additional shares, at a price of $23.00 per share. The aggregate gross proceeds of the offering were approximately $222 million, before deducting underwriting discounts and commissions and other offering expenses. The shares began trading on the Nasdaq Global Select Market on December 11, 2020 under the ticker symbol “FDMT.”Goldman Sachs & Co. LLC, BofA Securities and Evercore ISI acted as book-running managers for the offering.Registration...

Continue reading

Dr. Ana K. Stankovic, MD, PhD, Appointed to Fluidigm Board of Directors

SOUTH SAN FRANCISCO, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the appointment of Dr. Ana K. Stankovic, MD, PhD, MSPH, to the company’s Board of Directors. Dr. Stankovic is a seasoned leader with more than 30 years of research and development experience in academic, government, in vitro diagnostic and device industry settings.Dr. Stankovic is currently managing partner at Koliada Consulting, LLC, a firm focused on biotech, medical devices and in vitro diagnostics. Previously, she was Senior Vice President, World Wide Regional Medical Affairs and Global Health, for Becton, Dickinson and Company (BD). Dr. Stankovic served in senior roles at BD for more than a decade, leading...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.